S4E32 Brooke McDonald | R&D Engineering Series – Interview 6 of 6

Being an Engineer · 25 Aug 2023 · 45m · Episode 32

What this episode covers

Brooke McDonald, a staff R&D engineer at GT MedTech, discusses her career in medical device development, including her time at Stryker and her current work on brain tumor treatments. She emphasizes the importance of understanding clinical needs, managing the high volume of verification and validation testing, and the iterative nature of R&D. McDonald shares insights on overcoming the pressure of strict deadlines to ensure product safety and effectiveness, while highlighting the satisfaction of solving complex problems.

Other shows on the same ground, closest first.

  • Let's Combinate · 58m

    005 - “Compassionate Product Development” with Cameron Jones

    Cameron Jones, Co-Founder and CEO of Avasys Medical, discusses his journey from academic research at Vanderbilt, the University of Kentucky, and Johns Hopkins to founding a medical device company. He details the process of identifying unmet clinical needs through direct observation of clinicians, highlighting a specific case where a tourniquet design required 14 prototypes to meet size and safety constraints. Jones also explains his work on catheter interfaces to reduce infection risks and his philosophy on managing conflicts of interest while moonlighting between startups and large manufacturers.

  • Global Medical Device Podcast · 36m

    Project Management for Product Development of Medical Devices

    Devon Campbell, founder of Prodct, and Christie Johnson, founder of Kasota Engineering, discuss project management strategies for medical device development, arguing against rigid waterfall methodologies and complex Gantt charts. They advocate for a cyclical, agile-inspired approach that trusts engineering teams, uses coarse-grained high-level planning, and prioritizes early prototyping and testing to manage risk. The conversation highlights the importance of clear communication, information flow (via Design Structure Matrix), and integrating contract manufacturing partners early in the process to avoid bottlenecks and ensure successful product delivery.

  • Global Medical Device Podcast · 40m

    How Jon Speer Met His Most Frequent Guest: Mike Drues

    Jon Speer, host of the Global Medical Device Podcast and founder of Greenlight Guru, revisits his 2014 origin story with Mike Drues, president of Vascular Sciences, to discuss their past debates on medical device design controls. They analyze the tension between following the literal letter of FDA regulations versus understanding their intent, arguing that many companies fail because they treat compliance as a checkbox exercise rather than a rigorous engineering process. The conversation highlights the danger of assuming users know their own needs, which stifles revolutionary product development in favor of evolutionary improvements, and emphasizes the critical importance of validating validation methods and addressing off-label use in risk management.

  • Global Medical Device Podcast · 58m

    #392: Verification and Validation in MedTech: A Practical Guide with Devon Campbell

    Devon Campbell, a medical device consultant, explains the critical distinctions between verification (did we build the product right?) and validation (did we build the right product?) for early-stage medtech companies. He emphasizes that strong, testable user needs and design inputs are prerequisites for successful V&V, warning that weak requirements lead to validation failures. Campbell advocates for pre-verification testing to refine protocols and manage sample sizes, ensuring that design reviews and traceability are robust before formal regulatory submission.

  • Let's Combinate · 35m

    126 - Combination Products Collaboration, Turnover on MedTech/Pharma Project Teams, and Lessons from working with Intel's CEO with Mat Stratton, Founder of Coalition Ltd

    Mat Stratton, Founder of Coalition Ltd, discusses his 20-year career in MedTech and combination products, highlighting his early work with Intel CEO Andy Grove on deep brain stimulation and drug delivery systems. He explains how the high-speed culture of Intel, driven by Grove's Parkinson's disease advocacy, contrasted with the slow 4-10 year cycles of medical device development. Stratton identifies 'multifunctional collaboration' and employee turnover as key bottlenecks, proposing solutions like 'two-pizza teams' and regulatory stewardship to accelerate progress in highly regulated industries.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Being an Engineer. The episode itself belongs to its publisher.